Today's Low
₹ 16.90
Today's High
₹ 18.85
52 Weeks Low
₹ 136.10
52 Weeks High
₹ 209.00
Lower
₹ 14.20
Upper
₹ 21.30
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|
Total Current Assets | 17.9 | 14.6 | 13.0 |
Total Non-Current Assets | 2.7 | 2.2 | 1.3 |
Total Assets | 21.1 | 17.3 | 14.3 |
Total Current Liabilities | 9.0 | 10.8 | 14.0 |
Total Non-Current Liabilities | 2.5 | -0.1 | 0.3 |
Shareholder's Funds | 9.5 | 6.6 | -0.1 |
Total Liabilities | 21.1 | 17.3 | 14.3 |
The Industry Debt to Equity Ratio stands at 0.81, vs the Debt to Equity Ratio of -56.79, which results in a Positive aspect.
The Industry Price to BV stands at 1.39, vs the Price to BV of 7.99, which results in a Positive aspect.
The Industry Quick Ratio stands at 3.41, vs the Quick Ratio of 0.54, which results in a Negative aspect.
The Industry Current Ratio stands at 4.08, vs the Current Ratio of 0.93, which results in a Negative aspect.
Particulars | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|
Total Income | 59.1 | 35.7 | 26.7 |
Total Expenditure | 56.3 | 32.5 | 23.5 |
Operating Profit(Excl OI) | 3.1 | 3.5 | 4.0 |
Add: Other Income | 0.3 | 0.3 | 0.8 |
Operating Profit | 3.1 | 3.5 | 4.0 |
Less: Interest | 0.2 | 0.2 | 0.3 |
PBDT | 2.9 | 3.3 | 3.7 |
Less: Depreciation Amortization | 0.0 | 0.0 | 0.0 |
PBT & Exceptional Items | 2.9 | 3.3 | 3.7 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 2.9 | 3.3 | 3.7 |
Less: Taxation | -0.1 | 0.8 | 0.1 |
Profit After Tax | 3.0 | 2.5 | 3.6 |
Earnings Per Share | 0.0 | 0.0 | 0.0 |
The Industry PAT Growth stands at 26.91, vs the PAT Growth of 0.00, which results in a Negative aspect.
The Industry Dividend Yield stands at 1.58, vs the Dividend Yield of 0.30, which results in a Negative aspect.
The Industry PAT Margin stands at 17.45, vs the PAT Margin of 13.44, which results in a Negative aspect.
The Industry PE Ratio stands at 8.42, vs the PE Ratio of 41.82, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Profit Before Tax | 4.6 | 2.9 | 3.3 | 3.7 |
Tax Paid | -0.7 | 0.2 | 0.2 | -0.2 |
Adjustment | 0.8 | 0.3 | 0.0 | -0.4 |
Changes In Working Capital | 4.6 | 2.9 | 3.3 | 3.7 |
Cash Flow after changes in Working Capital | -6.2 | -4.0 | 2.9 | -3.4 |
Cash Flow from Operating Activities | -6.9 | -3.8 | 3.2 | -3.6 |
Cash Flow from Investing Activities | -0.1 | -0.1 | 0.0 | 0.0 |
Cash Flow from Financing Activities | 10.4 | 2.3 | -1.2 | 4.1 |
Net Cash Inflow / Outflow | 3.4 | -1.5 | 2.0 | 0.5 |
Opening Cash & Cash Equivalents | 1.0 | 2.5 | 0.5 | 0.1 |
Closing Cash & Cash Equivalent | 4.4 | 1.0 | 2.5 | 0.5 |
The Industry PCF RATIO stands at 22.78, vs the PCF RATIO of 0.00, which results in a Negative aspect.
The Industry PFCF Ratio stands at 66.38, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Net Sales | 129.0 | 130.2 | 162.1 | 219.7 |
Total Income | 129.1 | 130.3 | 162.3 | 221.0 |
Total Expenditure | 119.5 | 113.7 | 144.0 | 173.6 |
PBIDT (Excl OI) | 9.6 | 16.5 | 18.1 | 46.1 |
Other Income | 0.1 | 0.1 | 0.2 | 1.4 |
Operating Profit | 9.7 | 16.5 | 18.3 | 47.4 |
Interest | 2.0 | 0.9 | 0.8 | 1.3 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 7.7 | 15.6 | 17.5 | 46.1 |
Depreciation | 0.5 | 0.5 | 0.5 | 0.5 |
Profit Before Tax | 7.2 | 15.1 | 17.0 | 45.6 |
Tax | 4.4 | 5.3 | 4.4 | 13.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 2.8 | 9.8 | 12.6 | 32.6 |
Net Profit | 2.8 | 9.8 | 12.6 | 32.6 |
ADDITIONAL INFOS: | ||||
Equity Capital | 125.0 | 125.0 | 125.0 | 125.0 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 0.2 | 0.8 | 1.0 | 2.6 |
Operating Profit Margin | 7.5 | 12.7 | 11.3 | 21.6 |
Net Profit Margin | 2.2 | 7.5 | 7.8 | 14.8 |
The Industry Mcap Growth stands at 14.11, vs the Mcap Growth of 0.00, which results in a Negative aspect.
The Industry Net Sales Growth stands at 1.62, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 19.70 | 20.89 | 17.74 |
R3 | 18.92 | 19.03 | 17.37 |
R2 | 18.13 | 18.19 | 17.25 |
R1 | 17.57 | 17.68 | 17.12 |
Pivot | 16.78 | 16.84 | 16.78 |
S1 | 16.22 | 16.33 | 16.88 |
S2 | 15.43 | 15.49 | 16.75 |
S3 | 14.87 | 14.98 | 16.63 |
S4 | 14.30 | 12.79 | 16.26 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
4.89
Bullish
RSI
17.90
Bullish
ROC
-89.44
Bearish
UltimateOscillator
38.70
Neutral
Williams Indicator
-98.36
Bullish
CCI Indicator
-65.99
Neutral
MACD
0.00
Bearish
Stochastic Indicator
0.82
Bullish
ATR
13.61
High Volatility
Ex-Date | Ratio | Record Date |
---|---|---|
23-09-2022 | 4:1 | 23-09-2022 |
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
29-02-2024 | 0.50 | 5 | Interim |
22-09-2023 | 0.50 | 5 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
16-02-2024 | Stock Split & Interim Dividend |
08-02-2024 | Quarterly Results & Preferential Issue of shares & Stock Split |
07-11-2023 | Quarterly Results |
26-10-2023 | Rights Issue (Revised) & Increase in Authorised Capital The Board Meeting to be held on 25/10/2023 has been revised to 26/10/2023 |
25-10-2023 | Rights Issue & Increase in Authorised Capital & Inter alia, to transact the following business: 1. To consider and discuss the proposal for raising of funds by issuance of equity share or convertible bonds or debentures or any other securities, through permissible modes including but not limited to a rights issue, preferential issue or qualified institutions placement, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required. 2. To consider and discuss Increase in Authorised Share Capital. 3. Any other item with the permission of chair and majority of directors. |
07-09-2023 | General Purpose |
11-08-2023 | Quarterly Results |
17-05-2023 | Increase in Authorised Capital Inter alia, to transact the following business: 1. To consider and discuss the proposal for raising of funds by issuance of equity share or convertible bonds or debentures or any other securities, through permissible modes including but not limited to a rights issue, preferential issue or qualified institutions placement, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required. 2. To consider and discuss Increase in Authorised Share Capital 3. Any other Matter with the permission of the Chairman. |
20-04-2023 | Audited Results & Final Dividend & Quarterly Results Inter alia, To consider & approve the appointment of M/s. Brijesh Shah & Co., Company Secretaries as the Secretarial Auditor of the Company for the Financial Year 2023-24. |
25-03-2023 | Independent Director Meeting |
05-12-2022 | Fund raising/Other business matters |
29-11-2022 | Fund raising/Other business matters |
14-11-2022 | Financial results |
07-09-2022 | Other business matters |
04-08-2022 | Bonus/Other business matters |
07-04-2022 | Financial results/Other business matters |
14-03-2022 | Other business matters |
04-02-2022 | Other business matters |
15-12-2021 | Fund Raising/Other business matters |
03-12-2021 | Fund Raising/Other business matters |
13-11-2021 | Financial Results/Other business matters |
07-09-2021 | Other business matters |
29-06-2021 | Financial Results/Other business matters |